1
The Multicenter Oscillatory Ventilation for Acute Respiratory Distress Syndrome Trial
(MOAT2) excluded severe COPD and asthma patients from the RCT trial of the 3100B
HFOV. High frequency oscillatory ventilation is recognized as less effective in diseases
with increased airway resistance and using it in such cases may potentially result in air
trapping and hyperinflation.
3